Insta
Tata And CSIR-IGIB's CRISPR Based Low Cost Feluda COVID-19 Test Gets DCGI Nod
Coronavirus (Representative Image)
In a big boost for the nation's efforts against COVID-19, the Drug Controller General of India (DCGI) yesterday (19 September) gave its nod for the commercial launch of India's first Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) COVID-19 test called 'Feluda', reports Livemint.
Developed by the Tata Medical and Diagnostics Limited in a collaboration with CSIR-IGIB (Institute of Genomics and Integrative Biology), the test meets high-quality benchmarks with a sensitivity of 96 per cent and specificity of 98 per cent in the detection of the disease in a person's body.
The test is the world's first diagnostic test to deploy a specially adapted Cas9 protein to successfully detect the virus. Its genome-editing CRISPR technology has been indigenously developed and it works by detecting the genomic sequence of the COVID-19 virus.
The test achieves the accuracy levels of the traditional RT-PCR test kits, with quicker turnaround time, with less expensive equipment and better ease of usage.
It should also be noted that an official release issued by the Ministry of Science and Technology headed by Dr Harsh Vardhan mentioned that the CRISPR technology developed is a futuristic one, which can also be configured to detect several other pathogens in the future.
Support Swarajya's 50 Ground Reports Project & Sponsor A Story
Every general election Swarajya does a 50 ground reports project.
Aimed only at serious readers and those who appreciate the nuances of political undercurrents, the project provides a sense of India's electoral landscape. As you know, these reports are produced after considerable investment of travel, time and effort on the ground.
This time too we've kicked off the project in style and have covered over 30 constituencies already. If you're someone who appreciates such work and have enjoyed our coverage please consider sponsoring a ground report for just Rs 2999 to Rs 19,999 - it goes a long way in helping us produce more quality reportage.
You can also back this project by becoming a subscriber for as little as Rs 999 - so do click on this links and choose a plan that suits you and back us.
Click below to contribute.
Latest
